Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRRA | KALV | COLL | ||
| Company | Sierra Oncology Inc | Kalvista Pharmaceuticals Inc | Collegium Pharma | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 54.98 | 26.67 | 34.11 | ||
| High | 55.17 | 26.70 | 35.27 | ||
| Low | 54.98 | 26.63 | 33.51 | ||
| Latest | 54.99 | 26.66 | 34.58 | ||
| Change | +0.02 | +0.01 | +0.26 | ||
| % Change | +0.04% | +0.04% | +0.76% | ||
| Volume | 862,800 | 4,136,100 | 448,400 | ||
| 20-Day Average Volume | 396,690 | 5,553,850 | 483,460 | ||
| Previous Close | 54.97 | 26.65 | 34.32 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 54.91 | 21.16 | 33.90 | ||
| 20-Day Raw Stochastic | 62.96% | 98.77% | 61.58% | ||
| 20-Day Relative Strength | 77.35 | 71.99 | 47.39 | ||
| Weighted Alpha | +89.10 | +105.88 | +6.14 | ||
| Today's Opinion | 100% Buy | 100% Buy | 72% Sell | ||
| Previous Opinion | 100% Buy | 100% Buy | 72% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.07% since 06/23/22 | +39.14% since 04/27/26 | +5.49% since 04/27/26 | ||
| Low | 54.65 on 06/24/22 | 18.99 on 04/28/26 | 32.40 on 04/29/26 | ||
| High | 55.19 on 06/24/22 | 26.76 on 04/29/26 | 35.27 on 05/04/26 | ||
| 1-Month | |||||
| %Chg | +0.38% since 05/27/22 | +33.97% since 04/02/26 | +7.03% since 04/02/26 | ||
| Low | 54.58 on 05/31/22 | 18.66 on 04/24/26 | 31.54 on 04/06/26 | ||
| High | 55.19 on 06/24/22 | 26.76 on 04/29/26 | 36.27 on 04/14/26 | ||
| 3-Month | |||||
| %Chg | +69.83% since 03/30/22 | +77.97% since 02/04/26 | -28.23% since 02/04/26 | ||
| Low | 30.87 on 03/31/22 | 14.23 on 02/17/26 | 31.54 on 04/06/26 | ||
| High | 55.19 on 06/24/22 | 26.76 on 04/29/26 | 49.31 on 02/05/26 | ||
| 6-Month | |||||
| %Chg | +144.40% since 12/30/21 | +147.77% since 11/04/25 | -3.30% since 11/04/25 | ||
| Low | 14.91 on 01/24/22 | 10.41 on 11/07/25 | 31.54 on 04/06/26 | ||
| High | 55.19 on 06/24/22 | 26.76 on 04/29/26 | 50.79 on 12/29/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,342,801 | 1,365,066 | 1,112,208 | ||
| Shares Outstanding, K | 24,419 | 51,222 | 32,407 | ||
| Annual Sales | 0 | 49,080,000 | 780,570,000 | ||
| Annual Net Income | -94,660,000 | -109,520,000 | 62,870,000 | ||
| Last Quarter Sales | 0 | 13,690,000 | 205,450,000 | ||
| Last Quarter Net Income | -27,930,000 | -49,480,000 | 16,960,000 | ||
| 60-Month Beta | 0.01 | -0.12 | 0.76 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.33 on 05/06/22 | -0.92 on 11/10/25 | 2.04 on 02/26/26 | ||
| Earnings Date | 08/04/22 | 03/24/26 | 05/07/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 5.10 | ||